Back

Effect of blood pressure lowering treatment on the risk of atrial fibrillation: an individual-participant data meta-analysis

31 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Hypertension and the Heart Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Ana Catarina Pinho-Gomes

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Heart failure events in a clinical trial of arterial hypertension. The acquittal of the SPRINT trial.
Doctor P. Sobieraj (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Impact of comprehensive management on clinical outcomes in hypertensive patients with coronary artery disease: HIJ-CREATE sub-study
Associate Professor H. Ogawa (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Long-term antihypertensive treatment improves ventricular-arterial interaction in hypertensive patients: a 3-year follow-up study
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Impact of diastolic blood pressure on speckle tracking derived myocardial work components in a population of normotensive and untreated hypertensive patients
Doctor M. Lembo (Naples, IT)
Abstract Slides
Presentation thumbnail
Blood pressure response in exercise is associated with future cardiac structural alterations in hypertensive patients
Doctor I. Andrikou (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Hypertension and the Heart

The Event

Event poster

ESC Congress 2020

31 August 2020 08:30 CET
You may be interested in
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Webinar
Management of blood pressure: selected case-based advice
thumbnail
Congress Presentation
Add-on treatment with zilebesiran for inadequately controlled hypertension: KARDIA-2 RCT

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources